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Background: Sensitized fluorescence diagnostics are based on selective accumulation of photosensitizer in the
tissue where carcinogenesis has started. The present study compared topical 5-aminolevulinic acid (5-ALA)-based
fluorescence spectroscopy (FS) in vivo with conventional colposcopy for cervical intraepithelial neoplasia (CIN)
detection.
Methods: We enrolled 48 patients who were referred for colposcopy because of high-grade changes in cervical
cytology. Every inspected cervix was divided in to quadrants, and there were 174 quadrants included in the study.
Each patient had a cytological smear, colposcopy, FS and histopathological analysis. For FS, 3% 5-ALA cream was
used topically and after an average 135 min incubation, fluorescence spectra were recorded from the cervix in vivo.
FS and colposcopy results were correlated with histopathology.
Results: All spectra were evaluated by a ratio of the protoporphyrin IX fluorescence intensity at 634 nm and
autofluorescence intensity at 510 nm. For proper grouping of low-risk and high-risk cases, a threshold of 3.87 was
calculated. Data per quadrant showed that FS had higher sensitivity than colposcopy (71.7% vs 67.4%) but specificity
was greater for colposcopy (86.6% vs 75.6%). Combination of the methods showed higher sensitivity (88.0% vs 67.4%)
but reduced specificity (88.0% and 69.5%), but it had the highest number of correctly identified high-risk changes
and the highest (79.3%) accuracy. Data for each patient showed FS sensitivity of 91.2%, which was greater than for
colposcopy (88.2%). Higher overdiagnosis resulted in decreased specificity for fluorescence methodology—71.4% versus
78.6% for colposcopy. In both cases, accuracy was 85.4% and effectiveness was >80%, which means that both
methods can be used to determine high-risk cervical intraepithelial neoplasia. The diagnostic sensitivity of 97.1%
for this complementary diagnosis indicates that it could be the best choice for detection of high-risk changes.
Conclusions: 5-ALA-based FS is an objective method, requiring short-term administration for appropriate fluorescence
measurements. FS is a promising diagnostic tool with similar accuracy as colposcopy but with the potential advantage of
providing objective results.
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Worldwide, cervical cancer is the third most common
cancer among women, with an age-standardized incidence
rate of 15.3 per 100,000 and mortality rate of 7.8 per
100,000 [1]. Cervical cancer mostly affects younger women
aged 35–50 [2]. In 2011, 452 new cases of cervical cancer
were reported in Lithuania, which is one of the highest
rates of morbidity for cervical cancer rate among the Baltic
and Nordic countries [3,4].
Cervical intraepithelial neoplasia (CIN) is the poten-
tially premalignant transformation and abnormal growth of
epithelial cells on the surface of the cervix. A premalignant
lesion is always at a risk of malignant transformation if
stimulated by certain exogenous factors or conditions. The
main factor directly related to CIN development is persist-
ent human papillomavirus infection; mainly with high-risk
types 16, 18, 31 and 33 [5,6]. If CIN is diagnosed at the
appropriate time before cervical cancer manifestation, it
may be cured and cervical cancer avoided [7,8].
The main disadvantages of contemporary CIN detection
methods are high false-negative rates and low sensitivity of
cytology and low specificity of colposcopy. Some studies
showed that, in most cases, patients with high-grade smear
results and high-grade impression on colposcopy have an
acceptable overtreatment rate [9,10]. However conventional
colposcopy demands long-term training and achieves an
average ~48% (23–87%) specificity and has unsatisfactory
accuracy even in trained hands [7,11-13]. The low positive
predictive value seen with conventional colposcopy results
in unwarranted surgical procedures and an additional
burden on cervical cancer screening programs. These data
suggest that there is a need for new diagnostic methods to
improve or replace colposcopy for a clearer CIN diagnosis
and more individual approach.
Recently, there has been increased interest in optical
biopsy to determine pathological diagnoses in various
organs. Optical biopsy refers to any technique that uses
the interaction of light and tissue to provide information
about tissue morphology without the need for excision
[14-18]. Premalignant and malignant tissue differs from
healthy tissue in its morphology and cell growth rate,
which results in altered optical characteristics [16,19-21].
Most of the optical methods used in diagnostics are
based on different types of spectroscopy: fluorescence,
near infrared, Raman, diffuse reflectance, and similar
techniques [22-25]. However, the most widely used tech-
niques in clinical practice are based on fluorescence [26,27].
When light interacts with the molecules in the tissue they
become excited and may re-emit light of different colors
(fluorescence). The fluorescence of the tissue can be traced
by sensitive spectrometers and provide characteristic spec-
tra that reflect carcinogenicity of the tissue [22,23,27]. The
acceptance and suitability of these methods clinically are
determined by the diagnostic effectiveness, simplicity andlow cost of the procedures. Moreover, they are noninvasive
and can be repeated many times.
The potential of the fluorescence method to identify
normal and pathological tissues of the uterine cervix
was raised in 1994 [28,29]. The possibility was investi-
gated of autofluorescence being used for detection of
cervical neoplasia. Despite the demonstrated diagnostic
possibilities, tissue spectra vary both among patients and
within each individual patient. That complicates applica-
tion of the method, and it is difficult to maintain the
exact measurement conditions that could additionally
influence the intensity and spectral variations [28]. The
developed algorithms partially resolve this problem but
the lack of sufficient contrast between fluorescence of
healthy and neoplastic tissue encourages the use of
sensitized fluorescence.
One of the most widely used precursor exogenous
molecules in medical applications is 5-aminolevulinic
acid (5-ALA). 5-ALA is a precursor of the fluorescent
endogenous fluorophore, protoporphyrin IX (PpIX); an ex-
cess of which is produced in altered, especially cancerous
tissue. This results in accumulation of intracellular porphy-
rins, which increases tissue fluorescence in the red spectral
region of cancerous tissue [30]. Subsequent irradiation of
the lesion with visible light matching the highest absorption
of PpIX (~405 or ~630 nm) leads to red fluorescence
emission from PpIX, peaking at 635 nm. The different
accumulation of endogenous fluorophores in cancerous
and normal tissue causes differences in the red fluorescence
ratio between healthy and premalignant/malignant tissue,
which makes detection and analysis by fluorescence light
more applicable to discrimination between malignant and
nonmalignant tissues [31]. This intensity is governed by the
biological object itself, as well as many other conditions,
such as variations in different preparations, doses and
forms of application of 5-ALA, as well as different light
sources and incubation times.
The aim of this research was to compare the ability of
conventional colposcopy and 5-ALA-based FS for detec-
tion of CIN. From the fluorescence measurements, we
established low-risk and high-risk tissues for cancer devel-
opment. We created a methodology to identify from the
fluorescence spectra a universal independent threshold
value for determining high-risk tissues for cancer develop-
ment, eliminating possible measurement variations, de-
pending on individual characteristics of the organism and
technical errors.
Methods
The study was carried out at the National Cancer Institute
in Lithuania between December 2012 and January 2014.
The investigation protocol was approved by the Vilnius
Regional Research Ethics Committee and written informed
consent was obtained from all women. Inclusion criteria
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high-grade changes in cervical cytology, with no allergies or
history of porphyria. Exclusion criteria were unsatisfactory
or absent histopathological analysis, or inappropriate
colposcopy or FS measurements.
A total of 48 women with an average age of 36 years
(range 23–57 years) were enrolled. Each patient underwent
cytological smear, colposcopy, and FS. Every inspected
cervix was divided into four quadrants clockwise (Figure 1),
and every quadrant was analyzed as a separate case. In
total, 48 patients and 174 cervical quadrants were included.
Data of 18 cervical quadrants were excluded owing to
absence of histopathological analysis (uncertain marking
or absence of the quadrants after loop excision or biopsy
([8] cases), coagulation defects ([5] cases)) and inappro-
priate FS measurements (bleeding from the cervical tis-
sue during the investigation ([4] cases), device failure
during measurement [1 case]).
After colposcopy and FS, punch biopsy or loop elec-
trosurgical excision of the cervix for histopathological
analysis was performed. These tissue samples were
diagnosed as inflammatory (chronic cervicitis) (CIN0),
mild (CIN1), moderate (CIN2) or severe (CIN3) neo-
plastic. All cases were divided in two clinically signifi-
cant groups: low risk for cancer development (CIN0-1)
and high risk for cancer development (CIN2-3). The
histopathological diagnosis was provided for every
quadrant of the cervix. However, the diagnosis of separ-
ate cervical quadrant (per quadrant) and subsequent
final diagnosis of the whole cervix (per patient) wasFigure 1 Colposcopic view of the cervix and conventional marking
of the quadrants.concluded according to the highest degree of the neoplasia
discovered histopathologically.
Conventional colposcopy was performed using 3%
acetic acid with the Zoomscope Trulight video colposcope
(Wallach Surgical). Lugol’s iodine was not used. The colpo-
scopic examination was performed by two experienced
specialists. FS measurements and analysis were performed
with a spectroscopy system incorporating a 405-nm laser
diode, optical fiber probe, and filter, and spectrometer
QE65000 (Ocean Optics) was used to record fluorescence
spectra of a cervix in vivo (Figure 2). Each woman received
3% 3 g 5-ALA cream (precursor of the endogenous fluoro-
phore PpIX) topically as a visualizing agent on the cervix.
The cream was prepared in a local pharmacy and used
immediately afterwards. The incubation interval was
chosen according to the published scientific data that have
been shown to be diagnostically efficient [32-34]. The mini-
mum incubation time was 90 minutes and the maximum
was 180 minutes. The average and median of incubation
time was 135 minutes.
The fluorescence spectra measurements of cervical
tissues were done before 5-ALA application and after a
certain incubation time (Figure 3). The study was carried
out in a darkened room. During the examination, fluor-
escence spectra were acquired from 3–5 sites of every
cervical quadrant. Additional spectra corresponding to
healthy cervical tissue were registered from places that
were not typical of neoplastic development and that had
no signs of inflammation. All fluorescence spectra were
processed using Origin Pro software.
The fluorescence intensity ratio (R) was evaluated from
fluorescence spectra of sensitized cervical tissue (1):
R ¼ I 634 nmð Þ
I 510 nmð Þ ð1Þ
where I(634 nm) is fluorescence intensity at 634 nm
(maximum of the fluorescence band of the endogenous
fluorophore PpIX) and I(510 nm) is at the tissue auto-
fluorescence intensity maximum at 510 nm. Our previous
studies revealed that it is not correct to determine the
true state of the quadrant by averaging all fluorescence
spectra measured from that quadrant [35]. Therefore,
diagnosis according to fluorescence data was made on
the basis of one fluorescence spectrum that had the
highest R value. This value should correspond to the
highest degree of neoplasia.
In our previous study, we observed that R values are
scattered among patients [35], and the reliable threshold
value for healthy and pathological tissue differentiation
could not be estimated. Therefore, considering that
every patient has individual fluorophore composition
and metabolic characteristics (depending on age, men-
strual cycle, metabolic and endocrine functions) that
Figure 2 Scheme of the fluorescence spectroscopy system used for fluorescence photodetection of cervical lesions.
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the spectral measurements were additionally normalized
for every patient. The normalized value D, diagnostic factor,
was calculated as the proportion of R from individual quad-
rant and R from – healthy tissue of the particular women
cervix (2):
D ¼ R quadrantð Þ
R healthyð Þ ð2Þ
where D is diagnostic factor, R(quadrant) is individual
quadrant, and R(healthy) is healthy tissue of the particular
cervix.
Statistical analysis
Using Origin Pro 8, we performed statistical analysis of
the D values for all quadrants. To determine the normal-
ity of the distribution, we applied the Shapiro–Wilk test,
when the significance level was 0.05. We identified that
our data were not distributed normally, so for further
analysis, we applied nonparametric tests. To inspect the
raised hypotheses, we performed the Mann Whitney
Wilcoxon two-independent-samples tests. The statisti-
cally significant difference was when P(H0 = 0) < 0.05.
For proper grouping of LR and HR cases (D values), we
calculated the threshold value. For this reason Youden’sFigure 3 Fluorescence spectra from cervical tissue after ALA
application with PpIX fluorescence maximum at 634 nm and
autofluorescence maximum at 510 nm plus autofluorescence
spectra of the cervical tissue.index (J) was assessed. According to this criterion, the
threshold value is when J is the greatest. Statistical ana-
lysis of the collected material included sensitivity, speci-
ficity, positive and negative predictive values for FS,
colposcopy and combination of those methods, analyz-
ing diagnosis per patient and per cervical quadrant. For
evaluation of the method diagnostic efficiency, receiver
operating characteristic curves (ROCs) were plotted.
The diagnostic value was obtained by assessing area
under the curve (SROC). Area under the curve was 0.9–1.0,
the study could be evaluated as excellent; 0.8–0.9, very
good; 0.7–0.8, good; 0.6–0.7, tolerable; and 0.5–0.6,
deficient [39,40]. ROC analysis was performed using
MedCalc.Results
FS data analysis
During examination, 1295 in vivo spectra were acquired
(583 before 5-ALA application and 712 after). Before 5-
ALA application, no notable PpIX fluorescence was ob-
served in the cervical tissue. Typical fluorescence spectra
of different tissue types are presented in Figure 4. After
topical application of 5-ALA, PpIX fluorescence was
detected in the spectra of healthy and pathological tis-
sues (peaks at 634 and 703 nm). The typical fluores-
cence spectra of the cervical tissues, normalized to the
maximum of the tissue autofluorescence are presented
in Figure 5.
After histopathological analysis, we diagnosed 28%
and 47% of low-risk cases and then 71% and 53% of
high-risk cases per patient and per cervical quadrant,
respectively (Table 1).
The higher fluorescence intensity in the red spectrum
region was detected from neoplastic tissue compared
with healthy tissue. Normalization of fluorescence spec-
tra to autofluorescence peaks helps to overcome vary-
ing measurement conditions and allow unambiguous
evaluation of fluorescence spectra from different places.
The spectrum measured on the skin did not have a
peak specific for PpIX, which means that ALA cream
used topically on the cervix causes no PpIX production
in other parts of the body, showing no systemic accu-
mulation and therefore causing no notable side effects.
Figure 4 Fluorescence spectra from neoplastic, healthy cervical
tissue and skin before ALA application in the same patient.
Table 1 Histopathological diagnosis of analyzed cases
Diagnosis
(histopathology)
Total per patient Total per cervical quadrant
n = 48 n = 174
CIN 0 LOW RISK 11 (23%) 80 (46%)
CIN 1 3 (6%) 2 (1%)
CIN 2 HIGH RISK 2 (4%) 7 (4%)
CIN 3 32 (67%) 85 (49%)
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To obtain the threshold value for low- and high-grade
differentiation, D value was calculated for every quad-
rant and Youden’s index was calculated for every D
value (Figure 6). The peak value of Youden’s index was
0.427, which was reached at a D value of 3.87. This
value was chosen as the threshold value for low-risk
and high-risk cervical tissue differentiation. Subse-
quently, D values split into two groups (n(CIN0-1) = 88;
n(CIN2-3) = 86). After statistical analysis using the
Shapiro–Wilk test, at the 0.05 level of significance, the D
values of both groups were not normally distributed. To
establish whether these two groups were statistically differ-
ent, the Mann Whitney Wilcoxon test was performed for
independent samples and showed at the 0.05 level of
significance that the D values of the HR group were higher
than those of the LR group, P(H0 = 0) = 2,53 × 10
9. After
FS and D factor calculation, cervical quadrants, where D
was >3.87, were diagnosed as having high-risk neoplasia,
and all other quadrants were classified as low risk.Figure 5 Fluorescence spectra from neoplastic, healthy cervical
tissue and skin after topical ALA application in the same patient.Feasibility of FS for high/low risk cervical neoplasia
diagnosis
Further analysis was performed to evaluate the possibility
of using FS for differentiation of high- and low-risk lesions.
FS and colposcopy data were compared with the gold
standard of histopathological diagnosis (Table 2). It was
obvious that, based on fluorescence data, 20 low-risk quad-
rants were mistakenly diagnosed as high-risk CIN, and
in 26 quadrants, no pathological changes were seen, and
high-risk CIN was demonstrated histopathologically.
In determining the status of the cervical quadrants by
colposcopy, 73 quadrants were high-risk and 101 were
low-risk neoplastic. According to these results, the disease
was missed in 30 quadrants, while only 11 cases were
incorrectly diagnosed as high risk.
One of the potential applications of fluorescence diag-
nostics is as a complementary method to conventional
techniques. High-risk neoplasia was considered if at least
one method detected neoplastic changes. The data in
Table 2 show that when colposcopy and fluorescence
were combined, only 11 cases were missed, and combin-
ation of methods gave the best results. However, the 25
low-risk quadrants were mistakenly identified as high
risk, which led to unnecessary surgical procedures.
Following these results, the sensitivity, specificity, accur-
acy, test value, and positive and negative predictive values
for FS, colposcopy and combination of the methods were
calculated. Table 3 represents the statistical data for theFigure 6 Youden’s index in dependence of optimal threshold value.
Table 2 Comparison of fluorescence spectroscopy and
colposcopy with histopathology (per quadrant)
Histopathology
HR LR Total
Fluorescence spectroscopy HR 66 20 86
LR 26 62 88
Total 92 82 174
Fluorescence spectroscopy + colposcopy HR 81 25 106
LR 11 57 68
Total 92 82 174
Colposcopy HR 62 11 73
LR 30 71 101
Total 92 82 174
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than colposcopy (71.7% vs 67.4%), but specificity was
higher for colposcopy (86.6% vs 75.6%). The combination
of methods had higher sensitivity (88.0% vs 67.4%) but
reduced specificity (88.0% vs 69.5%). As mentioned above,
combination of the methods resulted in the highest
number of correctly identified high-risk changes and
the highest accuracy (79.3%). According to the ROC
curves, the diagnostic values (SROC) were similar and could
be considered as good. The effectiveness of the combined
diagnostic methods was the best (SROC = 0.788).
After quadrant analysis, data were summarized to pro-
vide the general diagnosis for the patient. The quadrant
with the severest neoplasia determined the diagnosis of
the whole cervix. Comparison of fluorescence and col-
poscopy data for each patient with the histopathological
findings are presented in Table 4.
Per patient analysis showed that FS failed to detect
only three high-risk cases from 34, while during colpos-
copy, four cases were missed. However, colposcopy
overdiagnosed three patients and FS four. These results
show that the two methods are comparable. Combin-
ation of the methods increases the number of correctly
diagnosed neoplasia (Table 4) and only one high-risk
case was missed. However, overdiagnosis also increased,Table 3 Sensitivity, specificity, accuracy, positive and negativ
colposcopy and combination of methods, analyzing cervical q
Fluorescence spectroscopy Colposcopy
n % 95% CI n %
Sensitivity 66/92 71.7 61.4- 80.6 62/92 67
Specificity 62/82 75.6 64.9- 84.4 71/82 86
Accuracy 128/ 174 73.5 - 133/174 76
PPV 66/86 76.7 - 62/73 84
NPV 62/88 70.5 - 71/101 70
Total 174 174with six patients being mistakenly diagnosed with high-
risk changes.
Full statistical analysis for the per patient results is
presented in Table 5
Sensitivity of FS was 91.2%, which was greater than
88.2% for colposcopy. Greater overdiagnosis resulted in
decreased sensitivity for FS—71.4% vs 78.6% for colpos-
copy. In both cases, the accuracy was 85.4%, and the ef-
fectiveness (SROC) was >80%, which means that the
value in determining the high-risk CIN was good for
both methods. On the contrary, the effectiveness of the
combined methods was <80%. Nevertheless, the sensitivity
of this combined diagnosis was 97.1%, indicating that it
was best for detection of high-risk lesions.
Discussion
We evaluated the use of 5-ALA-based FS for the detec-
tion of pathological areas in the cervix. Identification of
the diseased areas was estimated by measuring the fluor-
escence of PpIX, and more quantitative evaluation could
be done by calculating the ratio (R) between porphyrin
fluorescence and tissue autofluorescence. The additional
normalization of ratios (R) for the inspected areas of the
tissue to the (Rhealthy) value of healthy tissue enabled us
to calculate the diagnostic coefficients (D), and to obtain
threshold values for low- and high-risk differentiation.
The threshold value of 3.87 is the universal independent
number that could be used for CIN diagnosis.
Examination of the cervical quadrants yields the possi-
bility of specifying the localization of neoplastic regions.
However, because they were observed during the study,
the pathological areas could be small and missed during
measurement. Therefore, for precise localization of all
lesions, careful and fine scanning should be performed.
In other cases, accurate diagnostics could only be per-
formed per patient. The results of FS per quadrant in some
cases were influenced by difficulties during conization,
which resulted in incorrect margins of the quadrants and
mixed correct results. However, during routine procedures,
such situations cannot be fully avoided, therefore, suche predictive values for fluorescence spectroscopy,
uadrant diagnosis
Colposcopy + fluorescence (combined)
95% CI n % 95% CI
.4 56.8- 76.8 81/92 88.0 79.6- 93.9
.6 77.3- 93.1 57/82 69.5 58.4- 79.2
.4 - 138/174 79.3 -
.9 - 81/106 76.4 -
.3 - 57/68 83.8 -
174
Table 4 Comparison of fluorescence spectroscopy and
colposcopy with histopathology (per patient)
Histopathology
HR LR Total
Fluorescence spectroscopy HR 31 4 35
LR 3 10 13
Total 34 14 48
Fluorescence spectroscopy + colposcopy HR 33 6 39
LR 1 8 9
Total 34 14 48
Colposcopy HR 30 3 33
LR 4 11 15
Total 34 14 48
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sensitivity and specificity as a random error. Nevertheless,
these effects do not influence per patient diagnosis.
Per patient diagnosis showed 85.4% accuracy of FS in
identifying neoplastic changes, therefore, it has great diag-
nostic potential. However, to replace the conventional
methods, the threshold value must be revised and, if neces-
sary, corrected after data analysis from more patient cases.
Several studies show that the detection of porphyrin
fluorescence can improve the identification of the cer-
vical pre-malignancy. Only a few studies have been per-
formed using FS with 5-ALA. Hillemanns et al. [32]
showed that fluorescence imaging with 5-ALA after
60–90 minutes achieved similar sensitivity and specifi-
city compared with colposcopy in detecting CIN: 94%
and 51% versus 95% and 50%, respectively. However, the
specificity was markedly improved by FS, achieving 75%.
Sapoznikova et al. [41] reported that sensitized FS had a
diagnostic efficiency of 79.5% for cervical neoplasia.
When comparing colposcopy with 5-ALA-based FS, on
the one hand we have the experience of physicians and on
the other hand, we have the objectivity of the diagnostic
method, and one also should decide between overestimated
and underestimated CIN diagnosis. To date, it seems that
this should be a compromise because there is still no singleTable 5 Sensitivity, specificity, accuracy, positive and negativ
colposcopy and combination of methods, analyzing per patie
Fluorescence spectroscopy Colposcopy
n % 95% CI n %
Sensitivity 31/34 91.2 76.3- 98.0 30/34 88.2
Specificity 10/14 71.4 41.9- 91.4 11/14 78.6
Accuracy 41/48 85.4 - 41/48 85.4
PPV 31/35 88.6 - 30/33 90.9
NPV 10/13 76.9 - 11/15 73.3
Total 48 48method or combination of methods that can perfectly fulfill
all the desired requirements.
Nevertheless, fluorescence diagnostics appears promising
despite non- ideal results. Fluorescence is an objective
method, requiring only a short training for appropriate
fluorescence measurements, while colposcopy is highly
dependent on physicians’ experience and might be more
inaccurate when performed by less-trained hands. There is
plenty of room for improving the precision and consistency
of fluorescence measurement techniques. The additional
burden for FS was because the analysis was performed on
patients who already had high-grade cytology results. Al-
tered cytology could determine greater production of PpIX,
which results in elevated fluorescence intensity and finally
provide false-positive results and decreased specificity.
Moreover, the women who were diagnosed as having no
evidence or low risk of neoplasia had significant signs of
inflammation. The inflammation is not classified as malig-
nancy, but it changes the optical properties of cervical
tissue, therefore, the ability to differentiate inflammation
from neoplastic changes should further increase the diag-
nostic value of FS.
A possible clinical application could be a combination
of a porphyrin fluorescence image viewer and an in vivo
spectrum analysis system, which could be used for optical
biopsies. With this system, high-grade pre-cancer could be
diagnosed and treated in one session [32-34,41].
It is possible to define further directions for develop-
ment. FS is a powerful technique for detecting altered
tissues, however, additional attention should be paid to
differentiation/identification of the neoplastic changes
and inflammation.
Conclusions
By standardization of instrumentation and proper diag-
nostic algorithms it was possible to obtain an independent
threshold value for low- and high-risk differentiation,
Dthreshold = 3.87. Analysis using this threshold showed the
potential of FS for noninvasive identification of neoplastic
changes at an early stage, and it could be used for differen-
tiating high-risk changes. This method shows similare predictive values for fluorescence spectroscopy,
nt diagnosis
Colposcopy + fluorescence (combined)
95% CI n % 95% CI
72.5-96.6 33/ 34 97.1 84.6- 99.5
49.2-95.1 8/14 57.1 28.9- 82.2
- 41/ 48 85.4 -
- 33/ 39 84.6 -
- 8/9 88.9 -
48
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potential advantage of objective results. FS requires only a
short time of training to achieve appropriate measure-
ments, while colposcopy is highly dependent on physi-
cians’ experience, which is usually considered a major
factor in its success.
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